← Evidence map

ArticleBMJ open respiratory research2024

Effectiveness of nirmatrelvir-ritonavir versus azvudine for adult inpatients with severe or critical COVID-19.

Huan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 38599779